• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

WHO drug-resistant TB guidelines 2022: what is new?

作者信息

Migliori G B, Tiberi S

机构信息

Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy.

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.

出版信息

Int J Tuberc Lung Dis. 2022 Jul 1;26(7):590-591. doi: 10.5588/ijtld.22.0263.

DOI:10.5588/ijtld.22.0263
PMID:35768917
Abstract
摘要

相似文献

1
WHO drug-resistant TB guidelines 2022: what is new?《2022年世界卫生组织耐药结核病指南》：有哪些新内容？
Int J Tuberc Lung Dis. 2022 Jul 1;26(7):590-591. doi: 10.5588/ijtld.22.0263.
2
WHO strategies for the management of drug-resistant tuberculosis.世界卫生组织耐药结核病管理策略。
Arch Bronconeumol. 2017 Mar;53(3):95-97. doi: 10.1016/j.arbres.2016.07.015. Epub 2016 Oct 4.
3
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.广泛耐药结核病和极度耐药结核病的新定义：世界卫生组织的更新内容
Eur Respir J. 2021 Apr 8;57(4). doi: 10.1183/13993003.00361-2021. Print 2021 Apr.
4
Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.对氟喹诺酮类药物和链霉素耐药但对二线注射治疗敏感的耐多药结核病，其预后比广泛耐药结核病更好。
Clin Infect Dis. 2009 Mar 1;48(5):e50-2. doi: 10.1086/597010.
5
Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?世界卫生组织对广泛耐药结核病的新定义在实际应用中容易操作吗？
Eur Respir J. 2021 Jul 1;58(1). doi: 10.1183/13993003.00959-2021. Print 2021 Jul.
6
New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?世界卫生组织关于耐多药结核病的新治疗建议：我们准备得够充分吗？
Am J Respir Crit Care Med. 2019 Aug 15;200(4):514-515. doi: 10.1164/rccm.201902-0260LE.
7
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?世界卫生组织耐药结核病治疗综合指南中有哪些新内容？
Indian J Med Res. 2019 Mar;149(3):309-312. doi: 10.4103/ijmr.IJMR_579_19.
8
Management of drug-resistant TB with individualised DST--the way forward?采用个体化药敏试验管理耐多药结核病——前进之路？
J Assoc Physicians India. 2014 Jul;62(7):561-3.
9
Association of drug susceptibility testing results for first- and second-line drugs with treatment outcomes in patients with multidrug-resistant and extensively drug-resistant tuberculosis.耐多药和广泛耐药结核病患者一线及二线药物药敏试验结果与治疗转归的关联
Clin Infect Dis. 2015 Apr 15;60(8):1285-6. doi: 10.1093/cid/ciu1169. Epub 2014 Dec 30.
10
Impact of revised definitions for extensively drug-resistant TB on disease classification.广泛耐药结核病修订定义对疾病分类的影响。
Int J Tuberc Lung Dis. 2021 Sep 1;25(9):766-768. doi: 10.5588/ijtld.21.0229.

引用本文的文献

1
Distant ribose 2'-O-methylation of 23S rRNA helix 69 pre-orders the capreomycin drug binding pocket at the ribosome subunit interface.23S核糖体RNA螺旋69的远端核糖2'-O-甲基化在核糖体亚基界面预先形成了卷曲霉素药物结合口袋。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf618.
2
Host-Directed Therapies Based on Protease Inhibitors to Control and HIV Coinfection.基于蛋白酶抑制剂的宿主导向疗法以控制结核与HIV合并感染。
Microorganisms. 2025 Apr 30;13(5):1040. doi: 10.3390/microorganisms13051040.
3
Bedaquiline Delivery Innovations: A Review on Advancing MDR-TB Treatment Strategies.
贝达喹啉给药创新：推进耐多药结核病治疗策略的综述
Recent Adv Antiinfect Drug Discov. 2025;20(2):92-111. doi: 10.2174/0127724344318310241018113206.
4
15-year trends in efficacy and effectiveness of treatment outcomes in drug-resistant pulmonary TB.耐多药肺结核治疗效果的疗效和有效性的15年趋势
IJTLD Open. 2025 Apr 9;2(4):187-198. doi: 10.5588/ijtldopen.24.0620. eCollection 2025 Apr.
5
Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital.基于BPaL方案治疗耐多药结核病的安全性和有效性：一家意大利结核病转诊医院的首次经验。
Antibiotics (Basel). 2024 Dec 25;14(1):7. doi: 10.3390/antibiotics14010007.
6
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan.在巴基斯坦选定地点试点将BPaLM/BPaL用于耐多药结核病治疗的经验。
IJTLD Open. 2024 Nov 1;1(11):508-515. doi: 10.5588/ijtldopen.24.0369. eCollection 2024 Nov.
7
Accelerating TB regimen development: introducing FAST-TB.加速结核病治疗方案的研发：引入快速结核病（FAST-TB）。
IJTLD Open. 2024 Nov 1;1(11):483-485. doi: 10.5588/ijtldopen.24.0333. eCollection 2024 Nov.
8
Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?耐多药结核病的更新治疗指南：基于氯法齐明的治疗方案有多安全？
IJTLD Open. 2024 Nov 1;1(11):486-489. doi: 10.5588/ijtldopen.24.0490. eCollection 2024 Nov.
9
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis.较短疗程的耐多药或耐利福平结核病治疗方案的疗效与安全性：一项网状Meta分析
BMC Infect Dis. 2024 Oct 1;24(1):1087. doi: 10.1186/s12879-024-09960-3.
10
Integrating pathogen- and host-derived blood biomarkers for enhanced tuberculosis diagnosis: a comprehensive review.整合病原体和宿主来源的血液生物标志物以增强结核病诊断：全面综述。
Front Immunol. 2024 Aug 9;15:1438989. doi: 10.3389/fimmu.2024.1438989. eCollection 2024.